Earning Call Transcript
SeQuent Q1FY24 Con call Invite
AGM Notice - August 30, 2023
Disclosure under Regulation 30 -Earning Call Transcript
Newspaper Publication of Financial Results for Q4 FY 2022-23
Investor Meet Outcome – May 23, 2023
Outcome of Board Meeting – May 23, 2023
Investor Meet Intimation– May 24, 2023
Intimation of Board Meeting – May 23, 2023
Intimation for Closure of Trading Window – April 01, 2023
Disclosure under Regulation 30 -Earning Call Transcript
Newspaper Publication of Financial Results for Q3 FY 2022-23
Investor Meet Outcome - February 15, 2023
Outcome of Board Meeting – February 14, 2023
Investor Meet Intimation - February 15, 2023.
Intimation of Board Meeting – February 14, 2023.
Outcome of Postal Ballot – Results and Scrutinizer Report.
Announcement under Regulation 30 - Resignation of Director.
Newspaper Advertisement - Completion of dispatch of Postal Ballot Notice
Disclosure of Related Party Transactions for the half year ended September 30, 2022.
Notice of Postal Ballot
Outcome of Board Meeting – November 07, 2022
Disclosures under Regulation 30.
Investor Meet Intimation - November 08, 2022.
Intimation of Board Meeting – November 07, 2022.
AGM Proceedings - FY 2022.
Newspaper Advertisement-Post Dispatch of Notice of AGM
Newspaper Advertisement – 37th AGM to be held through VC / OAV
Newspaper Publication of Financial Results for Q1 FY 2022-23.
Re-constitution of Materiality Committee.
Outcome of Board Meeting held on August 08, 2022
Grant of Options under SeQuent ESOP 2020
Appointment of Chief Financial Officer of the Company
Disclosure of Related Party Transactions for the half year ended March 31, 2022
Secretarial Compliance Report FY 2021-22
Newspaper Publication of Financial Results for Q4 FY 2021-22
Constitution of “Materiality Committee”
Outcome of Board Meeting held on May 25, 2022
Investor Meet Intimation – May 26, 2022
Intimation of Board Meeting – May 25, 2022
Fire Incident at wholly owned subsidiary’s Unit
Allotment of Equity Shares under SeQuent ESOP 2020
Resignation of Chief Financial Officer
Grant of Options under SeQuent ESOP 2020
Outcome of Board Meeting held on February 11, 2022
Change in Managing Director and Chief Executive Officer of the Company
Consolidation of residual stake in Evance Group, Brazil
Acquisition of Nourrie
Intimation of Strike off Elysian Life Science Private Limited, a wholly owned subsidiary of the Company
Investor Meet Intimation – November 18 and 19, 2021
Outcome of Board Meeting held on November 01, 2021
Investor Meet Intimation – November 02, 2021
Intimation of Board Meeting – November 01, 2021
Intimation for Closure of Trading Window – October 01, 2021
Newspaper Advertisement – Extract of unaudited Financial results – June 30, 2021
Intimation of Board Meeting – June 30, 2021
Proceedings of Thirty Sixth Annual General Meeting of the Company
Post Newspaper AGM Intimation
Newspaper Advertisement – 36th AGM to be held through VC / OAV
Outcome of Board Meeting held on August 10, 2021
Investor Meet Intimation – August 11, 2021
Intimation of Board Meeting – August 10, 2021
Newspaper Advertisement – Extract of Audited Financial results – March 31, 2021
SeQuent announced EUGMP approval for its tablets dosage form in Turkey
Intimation for Closure of Trading Window – July 01, 2021
Outcome of Board Meeting held on June 30, 2021
Intimation for Closure of Trading Window – April 01, 2021
Related Party Transactions for the half year ended March 31, 2021
Related Party Transactions for the half year ended September 30, 2020
Newspaper Advertisement – Notice of Postal Ballot
Newspaper Advertisement – Extract of Unaudited Financial results – December 31, 2020
Press Release-January 28, 2021
Newspaper Advertisement – January 28, 2021
Investor Meet Intimation – February 4, 2021
Intimation of Board Meeting – February 3, 2021
Intimation for Closure of Trading Window – January 1, 2021
Schedule of meeting with investors/analysts – December 22, 2020
Outcome of Board Meeting held on December 14, 2020
Change in Director – Appointment of Dr. Fabian Kausche
Press Release – SeQuent announced launch of Citramox® LA in EU
Press Release – SeQuent announced launch of inhouse developed Halofusol® in EU
Related Party Transactions for the half year ended September 30, 2020
Newspaper Advertisement – Extract of Unaudited Financial results – September 30, 2020
Change in Directorate
Intimation pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Analysts/ Investors Conference call (Reschedule)
Update on Consolidation of Shareholding in Fendigo BV, Netherlands to make Fendigo BV a Wholly Owned Subsidiary of the Company
Investor Meet Intimation – November 6, 2020
Intimation of Board Meeting – November 6, 2020
Revision in Credit Rating
Completion of Sale of Investments held in Strides Pharma Science Limited
Request for reclassification of shareholding from ‘Promoter and Promoter Group’ to ‘Public’ Category’
Consolidation of shareholding in Provet Veteriner Urunleri San. Ve Tic. A. S., Turkey
Post Offer Advertisement
Pre-Offer Advertisement
Proceedings of Thirty Fifth Annual General Meeting of the Company
Board reconstitution
Press Release on Board reconstitution
Letter of Offer
Outcome of Board Meeting held on August 17, 2020
Change in Directorship
Withdrawal of Resolution No. 2 of the Notice dated July 30, 2020 convening the Thirty Fifth Annual General Meeting of the Company
Detailed Public Statement – Second Corrigendum
Recommendations of the Committee of Independent Directors (IDC) on the Open Offer
Outcome of Board Meeting held on August 12, 2020 and Press Release
Detailed Public Statement – Corrigendum
Newspaper Advertisement – Post dispatch of Notice of 35th AGM to be held through VC / OAVM
Newspaper Advertisement – Extract of Unaudited Financial results – June 30, 2020
Change in Directorate – Expiry of term of Mr. Narendra Mairpady, Independent Director
Newspaper Advertisement – 35th AGM to be held through VC / OAVM
Investor Meet Intimation – July 31, 2020
Intimation of Board Meeting – July 30, 2020
Intimation for Closure of Trading Window – July 1, 2020
Related Party Transactions for the year ended March 31, 2020
Draft Letter of Offer
Detailed Public Statement
Rescheduled Investor Meet Intimation – May 12, 2020
Intimation of Board Meeting – May 12, 2020
Investor Meet Intimation – May 12, 2020
Press Release - The Carlyle Group Enters into Binding Agreements to Acquire a Majority Stake in SeQuent
Intimation of Open Offer
Outcome of Board Meeting held on May 8, 2020
Press Release – Sequent Scientific provides Covid-19 Update
Intimation for Closure of Trading Window – April 1, 2020
Press Release – Sequent Scientific announces WHO-Geneva approval for its Vizag facility
Press Release - Sequent Scientific announces addition of new state-of-art Animal Health R&D Centre at Mumbai
Extract of Unaudited Financial Results in newspaper – December 31, 2019
Investor Meet Intimation – January 28, 2020
Intimation of Board Meeting – January 28, 2020
Intimation for Closure of Trading Window – January 1, 2020
Outcome of Board Meeting – November 13, 2019
Board Meeting – November 13, 2019
Disclosure of reasons for encumbrance by Promoters under regulation 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011
Outcome of Board Meeting – July 31, 2019
Intimation of Board Meeting – July 31, 2019
Investor Meet – July 31, 2019
Withdrawal of Credit Rating
Submission of half yearly disclosure on Related Party Transactions
Published Financials – May 14, 2019
Intimation of Board Meeeting – May 14, 2019
Investor Meet – May 14, 2019
Intimation of Credit Ratig
Allotment of Shares
Change in RTA
Published Financials February 2, 2019
Intimation of Board Meeting - February 01, 2019
Investor Meet - February 01, 2019
SRL receives EIR from USFDA
Analyst Meet
Investor Meet – November 02, 2018
Intimation of Board Meeting – November 02, 2018
AGM Proceedings
Published Financials
Investor Meet - August 10, 2018
Intimation of Board Meeting - August 09, 2018
Investor Meet – May 25, 2018
Intimation of Board Meeting - May 24, 2018
Outcome of Board Meeting – May 24, 2018
Outcome of Board Meeting – February 9, 2018
Sequent Board Meeting Intimation – February 9, 2018
Investors complaint Statement - 2017 -18 Quarter ended 3
Investors complaint Statement - 2017 -18 Quarter ended 2
Outcome of Tribunal Convened Meeting December 26, 2017
Outcome of Board Meeting November 9, 2017
Sequent Board Meeting Intiamtion - November 09, 2017
Sequent Board Meeting Intiamtion - August 03, 2017
Sequent Board Meeting Intiamtion - May 23, 2017
Sequent Board Meeting Intiamtion - Feb 10, 2017
Outcome of Board Meeting August 3, 2017
Outcome of Board Meeting May 23, 2017
Outcome of Postal Ballot - Results
Outcome of Board Meeting March 20, 2017
Outcome of Board Meeting February 10, 2017
Click Here for Archives
Sequent Outcome of Meeting November 10, 2016
Sequent Board Meeting Intimation November 10, 2016
Sequent Proceedings of AGM September 23, 2016
Sequent Outcome of Meeting September 23, 2016
Sequent AGM Advertisement September 1, 2016
Intimation to SE AGM September 23, 2016
Sequent Intimation to SE Book Closure
Sequent Form C Reg 7(2) SEBI (Prohibition of Insider Trading) Regulations, 2015 August 9, 2016
Sequent Form C Reg 7(2) SEBI (Prohibition of Insider Trading) Regulations 2015 May 17, 2016
Sequent Board Meeting Intimation August 12 2016
Submission of Consolidated Financials 2016-17
Update on Acquisition of Karizoo Group Spain
Sequent Intimation Alivira to acquire majority stake in Karizoo Group Spain
Grant of Employee Stock Options under SSL ESOP Scheme - 2010 of the Company
Sequent Outcome of Board Meeting May 14, 2016
Sequent Board Meeting Intimation May 14, 2016
Alivira to acquire controlling interest in Interchange Brazil
Sequent Intimation Schedule of Analyst or Institutional Investors Meeting
Sequent Update on Increase in Foreign Investment Limit March 14, 2016
Sequent Intimation for Record Date Equity Shares
Sequent Intimation for Appointment of Director
Sequent Intimation for Cessation from Directorship
Sequent Intimation to BSE Update on Vizag Plant February 5, 2016
Board Meeting Intimation February 11, 2016
Sequent Intimation Update on Indo Phyto Chemicals ("IPC")
Sequent Intimation to BSE Update on Vizag Plant January 29, 2016
Sequent Scientific to acquire controlling stake in Indo Phyto Chemicals Forays into steroids and hormones for Female Healthcare
Grant of Employee Stock Options under SSL ESOP Scheme-2010
Intimation Dispatch of Postal Ballot Notice
Authorised KMPs to determine materiality of events/information
Completion of acquisition of Topkim, Turkey